BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 14743896)

  • 1. Evaluation of hypervascular hepatocellular carcinoma in cirrhotic liver by means of helical CT: comparison of different contrast medium concentrations within the same patient.
    Sultana S; Morishita S; Awai K; Kawanaka K; Ohyama Y; Nakayama Y; Imuta M; Arakawa A; Yamashita Y
    Radiat Med; 2003; 21(6):239-45. PubMed ID: 14743896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamic contrast-enhanced MDCT of the liver: analysis of the effect of different iodine concentrations with the same total iodine dose in the same chronic liver disease patients.
    Tozaki M; Naruo K; Fukuda K
    Radiat Med; 2005 Dec; 23(8):533-8. PubMed ID: 16555560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal dose of contrast medium for depiction of hypervascular HCC on dynamic MDCT.
    Fujigai T; Kumano S; Okada M; Hyodo T; Imaoka I; Yagyu Y; Ashikaga R; Ishii K; Murakami T
    Eur J Radiol; 2012 Nov; 81(11):2978-83. PubMed ID: 22305012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aortic and hepatic enhancement and tumor-to-liver contrast: analysis of the effect of different concentrations of contrast material at multi-detector row helical CT.
    Awai K; Takada K; Onishi H; Hori S
    Radiology; 2002 Sep; 224(3):757-63. PubMed ID: 12202710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Moderate versus high concentration of contrast material for aortic and hepatic enhancement and tumor-to-liver contrast at multi-detector row CT.
    Awai K; Inoue M; Yagyu Y; Watanabe M; Sano T; Nin S; Koike R; Nishimura Y; Yamashita Y
    Radiology; 2004 Dec; 233(3):682-8. PubMed ID: 15486215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cirrhotic liver enhancement on dual-phase helical CT: comparison with noncirrhotic livers in 146 patients.
    Vignaux O; Legmann P; Coste J; Hoeffel C; Bonnin A
    AJR Am J Roentgenol; 1999 Nov; 173(5):1193-7. PubMed ID: 10541087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple-phase helical CT of the liver for detecting small hepatomas in patients with liver cirrhosis: contrast-injection protocol and optimal timing.
    Mitsuzaki K; Yamashita Y; Ogata I; Nishiharu T; Urata J; Takahashi M
    AJR Am J Roentgenol; 1996 Sep; 167(3):753-7. PubMed ID: 8751695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recommended iodine dose for multiphasic contrast-enhanced mutidetector-row computed tomography imaging of liver for assessing hypervascular hepatocellular carcinoma: multicenter prospective study in 77 general hospitals in Japan.
    Ichikawa T; Okada M; Kondo H; Sou H; Murakami T; Kanematsu M; Yoshikawa S; Shiosakai K; Hayakawa A; Awai K; Yoshimitsu K; Yamashita Y
    Acad Radiol; 2013 Sep; 20(9):1130-6. PubMed ID: 23931427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic enhancement in multiphasic contrast-enhanced MDCT: comparison of high- and low-iodine-concentration contrast medium in same patients with chronic liver disease.
    Furuta A; Ito K; Fujita T; Koike S; Shimizu A; Matsunaga N
    AJR Am J Roentgenol; 2004 Jul; 183(1):157-62. PubMed ID: 15208131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multi-detector row helical CT of the liver: quantitative assessment of iodine concentration of intravenous contrast material on multiphasic CT--a prospective randomized study.
    Tsurusaki M; Sugimoto K; Fujii M; Sugimura K
    Radiat Med; 2004; 22(4):239-45. PubMed ID: 15468944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arterioportal shunt: prevalence in small hemangiomas versus that in hepatocellular carcinomas 3 cm or smaller at two-phase helical CT.
    Byun JH; Kim TK; Lee CW; Lee JK; Kim AY; Kim PN; Ha HK; Lee MG
    Radiology; 2004 Aug; 232(2):354-60. PubMed ID: 15215556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of focal liver lesions at biphasic spiral CT: randomized double-blind study of the effect of iodine concentration in contrast materials.
    Hänninen EL; Vogl TJ; Felfe R; Pegios W; Balzer J; Clauss W; Felix R
    Radiology; 2000 Aug; 216(2):403-9. PubMed ID: 10924561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of hypervascular hepatocellular carcinoma in cirrhotic liver: comparison of different concentrations of contrast material with multi-detector row helical CT--a prospective randomized study.
    Sofue K; Tsurusaki M; Kawasaki R; Fujii M; Sugimura K
    Eur J Radiol; 2011 Dec; 80(3):e237-42. PubMed ID: 21067880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypervascular hepatocellular carcinomas: bolus tracking with a 40-detector CT scanner to time arterial phase imaging.
    Sultana S; Awai K; Nakayama Y; Nakaura T; Liu D; Hatemura M; Funama Y; Morishita S; Yamashita Y
    Radiology; 2007 Apr; 243(1):140-7. PubMed ID: 17329690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MDCT of the liver and hypervascular hepatocellular carcinomas: optimizing scan delays for bolus-tracking techniques of hepatic arterial and portal venous phases.
    Goshima S; Kanematsu M; Kondo H; Yokoyama R; Miyoshi T; Nishibori H; Kato H; Hoshi H; Onozuka M; Moriyama N
    AJR Am J Roentgenol; 2006 Jul; 187(1):W25-32. PubMed ID: 16794136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of varying contrast material iodine concentration and injection technique on the conspicuity of hepatocellular carcinoma during 64-section MDCT of patients with cirrhosis.
    Guerrisi A; Marin D; Nelson RC; De Filippis G; Di Martino M; Barnhart H; Masciangelo R; Guerrisi I; Passariello R; Catalano C
    Br J Radiol; 2011 Aug; 84(1004):698-708. PubMed ID: 21750137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimal arterial phase imaging for detection of hypervascular hepatocellular carcinoma determined by continuous image capture on 16-MDCT.
    Ma X; Samir AE; Holalkere NS; Sahani DV
    AJR Am J Roentgenol; 2008 Sep; 191(3):772-7. PubMed ID: 18716108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Minimally Required Iodine Dose for the Detection of Hypervascular Hepatocellular Carcinoma on 80-kVp CT.
    Goshima S; Kanematsu M; Noda Y; Kawai N; Kawada H; Ono H; Bae KT
    AJR Am J Roentgenol; 2016 Mar; 206(3):518-25. PubMed ID: 26901007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Depiction of hypervascular hepatocellular carcinoma with 64-MDCT: comparison of moderate- and high-concentration contrast material with and without saline flush.
    Matoba M; Kitadate M; Kondou T; Yokota H; Tonami H
    AJR Am J Roentgenol; 2009 Sep; 193(3):738-44. PubMed ID: 19696287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multidetector multiphase contrast-enhanced liver CT: prospective study comparing two contrast material injection rates on vascular and liver parenchyma enhancement in patients with varied cirrhotic status.
    Alimenti A; Spahr L; Loubeyre P
    J Comput Assist Tomogr; 2006; 30(3):368-71. PubMed ID: 16778608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.